Light activation of rat striatal cholinergic interneurons evokes striatal dopamine release. A, ChR2-eYFP detected in striatum (left) and PPN/LDT (right) after AAV2 injection to PPN/LDT (lower), and detected in striatum only after injection to striatum (upper), fixed tissue. B, GFP-immunopositive soma after striatal injection were co-immunopositive for ChAT. C, E, Mean profiles of [DA]o ± SEM versus time evoked by 1 or 4 pulses (25 Hz) of electrical (C) or light (E) stimulation, in control drug-free conditions or in the presence of DHβE (1 μm). Data are normalized to 1p peak [DA]o in control conditions. Control conditions (black lines), DHβE (red lines). D, F, Mean peak [DA]o normalized to control 1p for electrical (D) and light-evoked DA release (F) in control (black) and in the presence of DHβE (red). n = 3 rats, n = 4 sites. Two-way ANOVA with Sidak posttest comparisons of control versus DHβE: *p < 0.05, ***p < 0.001.